Abstract:Background: Topical Brimonidine is approved by FDA for the treatment of rosacea-associated erythema. It has antiinflammatory action, in additional to its vasoconstrictive activity, it preventes leucocyte recruitment via inhibition of transendothelial cells migration. Briominidine has been studied for many indications rather than rosacea with positive results. Objective: Review of the literature on the effectiveness of topical brimonidine in the treatment of various dermatological diseases. Methods: A comprehen… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.